Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Kengo Isshiki
CEO | Chief Executive Officer | - | 01.01.20 |
Director of Finance/CFO | - | 01.01.20 | |
Ofer Ekbali
COO | Chief Operating Officer | - | 01.04.20 |
Uri David
CTO | Chief Tech/Sci/R&D Officer | 98 | 01.10.19 |
Anat Nahmany
HRO | Human Resources Officer | - | 01.01.16 |
Ziva Mesika
LAW | General Counsel | 60 | 01.07.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | - | 01.04.20 | |
Mikio Himizu
BRD | Director/Board Member | - | 01.10.17 |
Hitoshi Izaki
BRD | Director/Board Member | - | 01.05.20 |
Kenji Taguchi
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 26 345 938 | 17 477 028 ( 66,34 %) | 0 | 66,34 % |
Unternehmenskontakt
NeuroDerm Ltd.
Ruhrberg Science Building Bell Entrance, Rabin Science Park
7670212, Rehovot
+972 8 946 2729
http://www.neuroderm.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+18,72 % | 125 Mrd. | |
+14,19 % | 108 Mrd. | |
-4,93 % | 24,21 Mrd. | |
+3,23 % | 22,78 Mrd. | |
-10,44 % | 17,96 Mrd. | |
-41,74 % | 16,43 Mrd. | |
-13,31 % | 16,37 Mrd. | |
+2,44 % | 13,58 Mrd. | |
+27,89 % | 11,66 Mrd. |